Royalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call Transcript November 6, 2024

Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.918 EPS, expectations were $0.93.

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter Earnings Conference Call. I would now like to turn the call over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.

George Grofik: Good morning,...